Medicine and Dentistry
Acute Pulmonary Embolism
42%
Biological Marker
19%
Blood Analysis
6%
Blood Pressure
8%
Cancer Incidence
5%
Cancer Staging
14%
Cancer Types
25%
Cohort Analysis
32%
Cohort Effect
30%
Cumulative Incidence
9%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
14%
Diffuse Large B-Cell Lymphoma
28%
Diseases
6%
Drug Megadose
7%
Electrophoresis
14%
Epileptic Absence
5%
Exhaled Breath Condensate
28%
External Jugular Vein
5%
Hazard Ratio
7%
Heart Output
6%
Hematological Cancer
14%
Hemodynamic
11%
Hemoglobin A1c
14%
Krukenberg Tumor
7%
Lower Limb
7%
Lower Limb Orthopedic Surgery
17%
Lung Vascular Resistance
14%
Magnetic Resonance Imaging
9%
Malignant Neoplasm
43%
Mantle Cell Lymphoma
14%
Mass Spectrum
14%
Medical Record
6%
Methotrexate
7%
Nitric Oxide
14%
Orthopedic Surgery
15%
Ovarian Cancer
14%
Overall Survival
22%
Pancreas Cancer
5%
Patient Registry
14%
Prognostic Factor
14%
Progression Free Survival
7%
Prostate Cancer
5%
Protein Analysis
14%
Pulmonary Embolism
45%
Right Ventricular Function
14%
Riociguat
14%
Second Cancer
14%
Thrombosis
28%
Venous Thromboembolism
100%
Keyphrases
Acute Pulmonary Embolism
28%
Ambulatory Cancer Patients
5%
Cancer Types
5%
Condensing Temperature
14%
Contact System
14%
Epidemiology
14%
Exhaled Breath Biomarkers
14%
Exhaled Breath Condensate
42%
Hematological Cancer
14%
High-risk Pulmonary Embolism
9%
Human Being
7%
Incidence Rate
7%
Indolent Lymphoma
5%
Khorana
5%
Khorana Score
14%
Leukemic Mantle Cell Lymphoma
14%
Lower Extremity Orthopedic Surgery
14%
Pulmonary Embolism
28%
Putative Biomarkers
14%
Riociguat
14%
Scandinavian
14%
Secondary CNS Involvement
14%
Thrombosis
14%
Uninvolved Immunoglobulins
5%
Venous Thromboembolism
14%